Creation and Implementation of a Preoperative Malignant Hyperthermia Screening Tool

J Nurs Care Qual. 2022 Jul-Sep;37(3):269-274. doi: 10.1097/NCQ.0000000000000610. Epub 2021 Nov 17.

Abstract

Background: Malignant hyperthermia (MH) is a potentially lethal pharmacogenetic disorder triggered by certain anesthetic agents. There is currently no standardized preoperative screening tool utilized to identify MH-susceptible individuals.

Local problem: This quality improvement (QI) project aimed to enhance preoperative screening for MH susceptibility (MHS) by implementing an evidence-based screening tool for surgical patients at 2 sites.

Methods: This prospective descriptive QI project evaluated the success of implementing an MHS screening tool preoperatively and its impact on the anesthesia plan.

Interventions: Anesthesia professionals included the screening tool in their preoperative interview for surgical patients so that positively screened patients could receive MH prevention measures.

Results: A total of 95 patients at site A and 234 patients at site B were screened using the MH tool, a cumulative total of 21 patients were positively screened, and 1 anesthetic plan was altered.

Conclusions: This MHS screening tool has the potential to prevent MH episodes when used consistently by staff.

MeSH terms

  • Humans
  • Malignant Hyperthermia* / diagnosis
  • Malignant Hyperthermia* / prevention & control
  • Prospective Studies